144 related articles for article (PubMed ID: 16287799)
1. Dangerous liaisons: the metabolic syndrome and nonalcoholic fatty liver disease.
Powell EE; Jonsson JR; Clouston AD
Ann Intern Med; 2005 Nov; 143(10):753-4. PubMed ID: 16287799
[No Abstract] [Full Text] [Related]
2. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
Hamaguchi M; Kojima T; Takeda N; Nakagawa T; Taniguchi H; Fujii K; Omatsu T; Nakajima T; Sarui H; Shimazaki M; Kato T; Okuda J; Ida K
Ann Intern Med; 2005 Nov; 143(10):722-8. PubMed ID: 16287793
[TBL] [Abstract][Full Text] [Related]
3. Summaries for patients. The metabolic syndrome and fatty liver disease.
Ann Intern Med; 2005 Nov; 143(10):I70. PubMed ID: 16287788
[No Abstract] [Full Text] [Related]
4. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
Chavez-Tapia NC; Mendez-Sanchez N; Uribe M
Ann Intern Med; 2006 Mar; 144(5):379; author reply 380. PubMed ID: 16520485
[No Abstract] [Full Text] [Related]
5. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
Kida Y; Sato T
Ann Intern Med; 2006 Mar; 144(5):379-80; author reply 380. PubMed ID: 16520484
[No Abstract] [Full Text] [Related]
6. Impact of fatty liver disease and metabolic syndrome on incident type 2 diabetes; a population based cohort study.
Mitsuhashi K; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukuda T; Fukui M
Endocr J; 2017 Nov; 64(11):1105-1114. PubMed ID: 28867686
[TBL] [Abstract][Full Text] [Related]
7. Alcohol consumption appears to protect against non-alcoholic fatty liver disease.
Moriya A; Iwasaki Y; Ohguchi S; Kayashima E; Mitsumune T; Taniguchi H; Ikeda F; Shiratori Y; Yamamoto K
Aliment Pharmacol Ther; 2011 Feb; 33(3):378-88. PubMed ID: 21118396
[TBL] [Abstract][Full Text] [Related]
8. Should nonalcoholic fatty liver disease be regarded as a hepatic illness only?
Tarantino G
World J Gastroenterol; 2007 Sep; 13(35):4669-72. PubMed ID: 17729388
[TBL] [Abstract][Full Text] [Related]
9. Alcohol and Obesity: A Dangerous Association for Fatty Liver Disease.
Mahli A; Hellerbrand C
Dig Dis; 2016; 34 Suppl 1():32-9. PubMed ID: 27548267
[TBL] [Abstract][Full Text] [Related]
10. From non-alcoholic fatty liver disease (NAFLD) to metabolic-associated fatty liver disease (MAFLD): A journey over 40 years.
Kuchay MS; Misra A
Diabetes Metab Syndr; 2020; 14(4):695-696. PubMed ID: 32442920
[No Abstract] [Full Text] [Related]
11. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
Dietrich P; Hellerbrand C
Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of nonalcoholic fatty liver disease in subjects with metabolic syndrome.
Castro-Martínez MG; Banderas-Lares DZ; Ramírez-Martínez JC; Escobedo-de la Peña J
Cir Cir; 2012; 80(2):128-33. PubMed ID: 22644007
[TBL] [Abstract][Full Text] [Related]
13. [Recent progress in the research of NASH/NAFLD in Japan].
Okanoue T
Nihon Shokakibyo Gakkai Zasshi; 2011 Jul; 108(7):1161-9. PubMed ID: 21737970
[No Abstract] [Full Text] [Related]
14. Fatty liver disease: the hepatic manifestation of metabolic syndrome.
Gastaldelli A
Hypertens Res; 2010 Jun; 33(6):546-7. PubMed ID: 20463681
[No Abstract] [Full Text] [Related]
15. Fatty liver and the metabolic syndrome.
Neuschwander-Tetri BA
Curr Opin Gastroenterol; 2007 Mar; 23(2):193-8. PubMed ID: 17268250
[TBL] [Abstract][Full Text] [Related]
16. [Fatty liver and steatohepatitis].
Saito T; Misawa K; Kawata S
Nihon Naika Gakkai Zasshi; 2005 Sep; 94(9):1855-9. PubMed ID: 16223146
[No Abstract] [Full Text] [Related]
17. Introduction: organ involvement in the cardiometabolic syndrome.
Hayden MR; Stump CS; Sowers JR
J Cardiometab Syndr; 2006; 1(1):16-24. PubMed ID: 17675904
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome from the view point of public health: with special reference to nonalcoholic fatty liver disease.
Watanabe T; Murata C; Watanabe Y
Nihon Koshu Eisei Zasshi; 2005 Nov; 52(11):934-42. PubMed ID: 16408478
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain.
Caballería L; Pera G; Auladell MA; Torán P; Muñoz L; Miranda D; Alumà A; Casas JD; Sánchez C; Gil D; Aubà J; Tibau A; Canut S; Bernad J; Aizpurua MM
Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):24-32. PubMed ID: 19730384
[TBL] [Abstract][Full Text] [Related]
20. Biphasic effect of alcohol intake on the development of fatty liver disease.
Takahashi H; Ono M; Hyogo H; Tsuji C; Kitajima Y; Ono N; Eguchi T; Fujimoto K; Chayama K; Saibara T; Anzai K; Eguchi Y
J Gastroenterol; 2015 Nov; 50(11):1114-23. PubMed ID: 25733100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
